Hormonal
Physical exercise induces white adipose tissue browning through the secretion of myokines such as Irisin, FGF21, and Beta-Aminoisobutyric acid, which upregulate UCP1 and thermogenic genes.
Engage in regular physical exercise to trigger the release of myokines like Irisin and FGF21. These molecules signal your white fat to turn into metabolically active beige fat, increasing your energy expenditure and metabolic efficiency. The specific type of exercise is less important than consistency in triggering these hormonal responses.
Physical exercising copes with increased levels of specific molecules, including Beta-Aminoisobutyric acid, irisin, and Fibroblast growth factor 21 (FGF21), which induce adipose tissue browning.
Why this rating
Review paper summarizing mechanisms; specific dosing protocols for exercise are not detailed in the abstract.
Source
Browning of the white adipose tissue regulation: new insights into nutritional and metabolic relevance in health and diseases
Sabrina Azevedo Machado et al. · Nutrition & Metabolism · 2022
DOI 10.1186/s12986-022-00694-0
More from this paper
- Dietary interventions including capsaicin, n-3 polyunsaturated fatty acids, and intermittent fasting promote white adipose tissue browning and metabolic efficiency, whereas a Western diet inhibits this process.Moderate
- Cold exposure activates the beta-3 adrenergic receptor system, leading to UCP1 upregulation and non-shivering thermogenesis, although human response varies significantly compared to rodents.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →